These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2686096)

  • 1. An overview of maternal toxicity and prenatal development: considerations for developmental toxicity hazard assessments.
    Chernoff N; Rogers JM; Kavlock RJ
    Toxicology; 1989 Dec; 59(2):111-25. PubMed ID: 2686096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and interpretation of maternal toxicity in Segment II studies: issues, some answers, and data needs.
    Rogers JM; Chernoff N; Keen CL; Daston GP
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):367-74. PubMed ID: 15982694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of pharmacokinetic variables in reproductive and developmental toxicity.
    Neubert D
    Xenobiotica; 1988 Jan; 18 Suppl 1():45-58. PubMed ID: 3278490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A perspective on the significance of maternally mediated developmental toxicity.
    Hood RD
    Regul Toxicol Pharmacol; 1989 Oct; 10(2):144-8. PubMed ID: 2813867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of maternal toxicity on the outcome of developmental toxicity studies.
    Paumgartten FJ
    J Toxicol Environ Health A; 2010; 73(13-14):944-51. PubMed ID: 20563928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental toxicity: web resources for evaluating risk in humans.
    Polifka JE; Faustman EM
    Toxicology; 2002 Apr; 173(1-2):35-65. PubMed ID: 11955683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the adult developmental relationship in prescreening for developmental hazards.
    Johnson EM; Christian MS; Dansky L; Gabel BE
    Teratog Carcinog Mutagen; 1987; 7(3):273-85. PubMed ID: 2888206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal factors in developmental toxicity.
    DeSesso JM
    Teratog Carcinog Mutagen; 1987; 7(3):225-40. PubMed ID: 2888203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to defining the relationship of maternal and developmental toxicity.
    Schardein JL
    Teratog Carcinog Mutagen; 1987; 7(3):255-71. PubMed ID: 2888205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiopulmonary consequences of gestational toxicant exposure: Symposium overview at the 56th annual SOT meeting, Baltimore, MD.
    Stapleton PA; Wingard CJ; Nurkiewicz TR; Holloway AC; Zelikoff JT; Knudsen TB; Rogers LK
    Reprod Toxicol; 2018 Aug; 79():16-20. PubMed ID: 29709519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of adult toxicity in developmental versus prechronic toxicology studies.
    Schwetz BA; Moorman MP
    Teratog Carcinog Mutagen; 1987; 7(3):211-23. PubMed ID: 2888202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental toxicity risk assessment: consensus building, hypothesis formulation, and focused research.
    Kimmel CA
    Drug Metab Rev; 1996; 28(1-2):85-103. PubMed ID: 8744591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hierarchization of animal teratology findings for improving the human risk evaluation of drugs.
    Guittina P; Eléfant E; Saint-Salvi B
    Reprod Toxicol; 2000; 14(4):369-75. PubMed ID: 10908840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative parameter sensitivity in prenatal toxicity studies with substances classified as developmental toxicants.
    Rorije E; van Hienen FJ; Dang ZC; Hakkert BH; Vermeire T; Piersma AH
    Reprod Toxicol; 2012 Sep; 34(2):284-90. PubMed ID: 22652463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward a biologically based dose-response model for developmental toxicity of 5-fluorouracil in the rat: acquisition of experimental data.
    Lau C; Mole ML; Copeland MF; Rogers JM; Kavlock RJ; Shuey DL; Cameron AM; Ellis DH; Logsdon TR; Merriman J; Setzer RW
    Toxicol Sci; 2001 Jan; 59(1):37-48. PubMed ID: 11134542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F; Pino M; DeLise B; Guittin P; Barbellion S; Brunel P; Potdevin S; Bergmann B; Hofmann T; Lerman S; Clark RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):55-68. PubMed ID: 15098199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental pollutants and lifestyle factors induce oxidative stress and poor prenatal development.
    Al-Gubory KH
    Reprod Biomed Online; 2014 Jul; 29(1):17-31. PubMed ID: 24813750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal toxicity and the identification of inorganic arsenic as a developmental toxicant.
    Golub MS
    Reprod Toxicol; 1994; 8(4):283-95. PubMed ID: 7949754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of physiologically based models of pregnancy and lactation for their application in children's health risk assessments.
    Corley RA; Mast TJ; Carney EW; Rogers JM; Daston GP
    Crit Rev Toxicol; 2003; 33(2):137-211. PubMed ID: 12708613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on the role of maternal toxicity on developmental toxicity.
    Tyl RW
    Birth Defects Res B Dev Reprod Toxicol; 2012 Jun; 95(3):262-6. PubMed ID: 22706915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.